Based on observations on the involvement of MIR4435-2HG in MTOR and EMT signaling pathways, we speculate that MIR4435-2HG may mediate interactions between cancer cells and stromal cells by metabolic reprogramming, which may be a future direction for studies. This evidence concerns the gene MTOR and cancer.